✦ LIBER ✦

Sex Differences in Neointimal Hyperplasia Following Endeavor Zotarolimus-Eluting Stent Implantation

✍ Scribed by Daisaku Nakatani; Junya Ako; Jennifer A. Tremmel; Katsuhisa Waseda; Hiromasa Otake; Bon-Kwon Koo; Akiyoshi Miyazawa; Yoichiro Hongo; Seung-Ho Hur; Ryota Sakurai; Paul G. Yock; Yasuhiro Honda; Peter J. Fitzgerald

Book ID: 113448413
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 247 KB
Volume: 108
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2011.05.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Asymmetric Stent Expansion on

Impact of Asymmetric Stent Expansion on Neointimal Hyperplasia Following Sirolimus-Eluting Stent Implantation

✍ Hideaki Kaneda; Junya Ako; Yasuhiro Honda; Mitsuyasu Terashima; Yoshihiro Morino 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Angioscopic differences in neointimal co

Angioscopic differences in neointimal coverage between zotarolimus- and everolimus-eluting stents

✍ Koshi Matsuo; Yasunori Ueda; Yasuhiro Akazawa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Five-year clinical follow-up after impla

Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study

✍ Ian T. Meredith; John Ormiston; Robert Whitbourn; I. Patrick Kay; David Muller; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract Objective: To evaluate the 5‐year clinical outcomes of patients treated with the Endeavor zotarolimus‐eluting stent (ZES) in the ENDEAVOR I first‐in‐human study. Background: ENDEAVOR I was a prospective, nonrandomized, multicenter study of the Endeavor ZES in 100 consecutive patients wi

Impact of Intravascular Ultrasound Lesio

Impact of Intravascular Ultrasound Lesion Characteristics on Neointimal Hyperplasia Following Sirolimus-Eluting Stent Implantation

✍ Hideaki Kaneda; Tomomi Koizumi; Junya Ako; Mitsuyasu Terashima; Yoshihiro Morino 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Four-Year Clinical Follow-Up After Impla

Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study

✍ Ian T. Meredith; John Ormiston; Robert Whitbourn; I. Patrick Kay; David Muller; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 93 KB

TCT-232: Impact of Stent Size and Length

TCT-232: Impact of Stent Size and Length on Neointimal Hyperplasia After Resolute Zotarolimus-Eluting Stent Implantation: Insights From RESOLUTE Trials

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 110 KB